TABLE 1.
Inhibitor | XTT reduction (%)a by biofilms after 48 h
|
||
---|---|---|---|
Strain GDH 2346 | Strain SC5314 | Strain CAI4 | |
Aspirin | 20.6 ± 2.8b | 12.3 ± 2.2b | 4.6 ± 0.8b |
Diclofenac | 57.6 ± 3.6b | 31.2 ± 1.1b | 59.7 ± 2.6b |
Ibuprofen | 82.7 ± 3.9c | 81.7 ± 6.3c | 88.4 ± 6.3d |
Indomethacin | 92.7 ± 2.8 | 95.8 ± 4.2 | 85.7 ± 13.8 |
Piroxicam | 93.7 ± 2.9 | 84.4 ± 6.0 | 80.6 ± 7.4 |
Celecoxibe | 77.3 ± 2.7b | 79.5 ± 7.4c | 94.0 ± 3.9 |
Etodolace | 62.9 ± 1.5b | 49.4 ± 3.8b | 73.4 ± 3.6b |
Meloxicame | 88.4 ± 7.0d | 84.5 ± 3.0b | 81.3 ± 2.4b |
Nimesulidee | 84.8 ± 3.5c | 86.7 ± 7.8d | 94.4 ± 6.3 |
Inhibitors were present during the adhesion period and throughout the 48-h growth period. XTT reduction is expressed as a percentage of that of control biofilms of the same strain incubated in the absence of inhibitor. The results are means ± standard errors of the means of at least two independent experiments carried out in triplicate. Mean ± standard error of the mean values (A492) for the controls were 2.413 ± 0.069, 2.676 ± 0.066, and 2.833 ± 0.072 for strains GDH 2346, SC5314, and CAI4, respectively.
Value significantly different at P < 0.001 from that for the control.
Value significantly different at P < 0.01 from that for the control.
Value significantly different at P < 0.05 from that for the control.
COX-2 inhibitor.